Estee Lauder (EL) Tops Q1 EPS by 5c, Misses on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Estee Lauder (EL) PT Lowered to $70 at B.Riley
November 4, 2024 5:16 AM ESTB.Riley analyst Anna Glaessgen lowered the price target on Estee Lauder (NYSE: EL) to $70.00 (from $95.00) while maintaining a Neutral rating.
The analyst comments "Worsening Chinese consumer sentiment drives meaningful reduction to FY25 estimates. The prestige beauty industry in... More
Evercore ISI Reiterates Outperform Rating on Estee Lauder (EL)
October 31, 2024 8:55 AM EDTEvercore ISI analyst Robert Ottenstein reiterated an Outperform rating and $130.00 price target on Estee Lauder (NYSE: EL).
The analyst comments "Estees reliance on China, mainland and throughout travel corridors, is underscored yet again. There are no multiple engines of growth, at least not profitable ones, and as Asia Travel Retail stopped taking orders, operating losses elsewhere surface. Results suggest significant organizational and commercial weaknesses and challenges outside Asia. For... More
Citi Downgrades Estee Lauder (EL) to Neutral
October 31, 2024 8:53 AM EDTCiti analyst Filippo Falorni downgraded Estee Lauder (NYSE: EL) from Buy to Neutral with a price target of $80.00 (from $105.00).
The analyst comments "Even though the bar was very low for EL, F1Q25 results and guidance update were much worse than... More



